Announcement & Circular > Article details

Voluntary Announcement Approval Obtained for Initiating Clinical Trial for the Innovative ADC Candidate BA1301 for Injection in China

2023.01.09 | Boan Biotech,Shandong Boan Biotech, Boan Innovative Antibodies,Boan Biosimilar

Contact us

No.39 Keji Avenue High-Tech Industrial Development Zone Yantai, Shandong Province, China

(86)0535-4379111

Follow me